Financials
Financial year 2025
Dr. Georges De Moor, Klinische Biologie from Zwalm, company number BE0463329903, closed financial year 2025 with a result of € 51,976 after tax. For that financial year Dr. Georges De Moor, Klinische Biologie recorded a gross margin of € 79,411 and equity of € 299,061. Compared with financial year 2024, the result moved from € 32,967 to € 51,976. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 299,061
▼ 26% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 51,976
▲ 58% vs 2024
Profit after tax over the fiscal year.
€ 66,452
▼ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 155,627 paid out
More than the year’s profit went to the shareholders; reserves fell.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,722
▲ 171% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,270
▲ 186% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 172,600 | € -644 | € 56,654 | € 79,411 | ▲ 40% |
| Profit after taxes | € 108,690 | € -18,156 | € 32,967 | € 51,976 | ▲ 58% |
| Equity | € 489,109 | € 422,300 | € 402,712 | € 299,061 | ▼ 26% |
| Total debts | € 122,265 | € 78,366 | € 63,123 | € 203,102 | ▲ 222% |
| Cash | € 149,193 | € 211,539 | € 124,809 | € 66,452 | ▼ 47% |
| Land & buildings | € 90,700 | € 52,000 | € 52,000 | € 52,000 | |
| Retained profit | € 470,516 | € 403,708 | € 384,120 | € 280,469 | ▼ 27% |
| Dividend | € 166,147 | € 48,652 | € 52,555 | € 155,627 | ▲ 196% |
| Bank debt | € 10,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 611,374 | € 500,666 | € 465,835 | € 502,163 | ▲ 8% |
Key figures of Dr. Georges De Moor, Klinische Biologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Georges De Moor, Klinische Biologie?
What happened at Dr. Georges De Moor, Klinische Biologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 51,976 (▲ 58% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Zwalm. KBO
In short
From € 108,690 profit in 2022 to € 51,976 profit in 2025.
Paid € 97,635 in corporate taxes since 2022.
Best year ever: 2022, with € 108,690 profit.
Paid out € 422,981 in dividends to the owners in total.
Management
Behind Dr. Georges De Moor, Klinische Biologie is Georges De Moor. Georges De Moor is also behind MATRICES.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Sint-Annastraat(Roz) 43
9630 Zwalm
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0463.329.903
- VAT number
- BE 0463.329.903
- Registered office
- Sint-Annastraat(Roz) 43, 9630 Zwalm
- Names & denominations
- Dr. Georges De Moor, Klinische Biologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 May 1998
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Activiteiten van medisch specialisten